Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry-Reference-Cited by-同舟云学术

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

Published:2020-04-01 Issue:9 Volume:51 Page:880-888
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Biemans Vince B. C.¹²^ORCID,Sleutjes Jasmijn A. M.³,de Vries Annemarie C.³,Bodelier Alexander G. L.⁴,Dijkstra Gerard⁵,Oldenburg Bas⁶,Löwenberg Mark⁷,van Bodegraven Adriaan A.⁸,van der Meulen-de Jong Andrea E.⁹,de Boer Nanne K. H.¹⁰,Srivastava Nidhi¹¹,West Rachel L.¹²,Römkens Tessa E. H.¹³,Horjus Talabur Horje Carmen S.¹⁴,Jansen Jeroen M.¹⁵,van der Woude C. Janneke³,Hoekstra Jildou⁴,Weersma Rinse K.⁵,van Schaik Fiona D. M.⁶,Hoentjen Frank¹,Pierik Marieke J.²,

Affiliation:

1. Department of Gastroenterology and Hepatology; Radboud University Medical Centre; Nijmegen The Netherlands

2. Department of Gastroenterology and Hepatology; Maastricht University Medical Centre; Maastricht The Netherlands

3. Erasmus Medical Centre; Rotterdam The Netherlands

4. Amphia Hospital; Breda The Netherlands

5. University Medical Centre Groningen; University of Groningen; Groningen The Netherlands

6. University Medical Centre Utrecht; Utrecht The Netherlands

7. Amsterdam University Medical Centre; Academic Medical Centre; Amsterdam The Netherlands

8. Zuyderland Medical Centre; Sittard The Netherlands

9. Leiden University Medical Centre; Leiden The Netherlands

10. Amsterdam University Medical Centre; Vrije Universiteit; Amsterdam Gastroenterology & Metabolism research institute; Amsterdam The Netherlands

11. Haaglanden Medisch Centre; The Hague The Netherlands